Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 96% | 3009.61 | 1386 / 1445 | 99% | 98.26 | 182 / 183 |
| breast | 98% | 649.02 | 450 / 459 | 91% | 25.24 | 1017 / 1118 |
| lung | 100% | 1275.18 | 576 / 578 | 89% | 23.27 | 1024 / 1155 |
| ovary | 97% | 712.25 | 175 / 180 | 86% | 16.61 | 369 / 430 |
| uterus | 98% | 737.05 | 167 / 170 | 84% | 32.29 | 386 / 459 |
| stomach | 91% | 614.07 | 327 / 359 | 80% | 22.52 | 230 / 286 |
| adrenal gland | 97% | 938.60 | 251 / 258 | 73% | 8.91 | 169 / 230 |
| intestine | 99% | 1198.43 | 952 / 966 | 72% | 18.04 | 380 / 527 |
| kidney | 98% | 649.15 | 87 / 89 | 69% | 10.00 | 626 / 901 |
| thymus | 96% | 596.24 | 628 / 653 | 68% | 8.18 | 412 / 605 |
| pancreas | 69% | 251.27 | 227 / 328 | 94% | 29.54 | 167 / 178 |
| bladder | 86% | 505.86 | 18 / 21 | 71% | 19.59 | 358 / 504 |
| skin | 69% | 786.85 | 1247 / 1809 | 77% | 16.02 | 364 / 472 |
| prostate | 95% | 537.97 | 232 / 245 | 24% | 2.24 | 120 / 502 |
| spleen | 100% | 3004.14 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.78 | 1 / 1 |
| adipose | 99% | 841.22 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 644.35 | 1285 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 2028.93 | 881 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 57.31 | 42 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 17.78 | 25 / 29 |
| liver | 62% | 227.93 | 139 / 226 | 18% | 2.15 | 74 / 406 |
| brain | 19% | 71.16 | 502 / 2642 | 58% | 8.45 | 409 / 705 |
| heart | 76% | 293.36 | 652 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 11% | 0.90 | 9 / 80 |
| muscle | 7% | 19.66 | 57 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0034058 | Biological process | endosomal vesicle fusion |
| GO_0045087 | Biological process | innate immune response |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SAMD9 |
| Protein name | Sterile alpha motif domain containing 9 Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9) |
| Synonyms | C7orf5 OEF1 DRIF1 KIAA2004 |
| Description | FUNCTION: Double-stranded nucleic acid binding that acts as an antiviral factor by playing an essential role in the formation of cytoplasmic antiviral granules . May play a role in the inflammatory response to tissue injury and the control of extra-osseous calcification, acting as a downstream target of TNF-alpha signaling. Involved in the regulation of EGR1, in coordination with RGL2. May be involved in endosome fusion. . |
| Accessions | ENST00000620985.4 C9JKF1 ENST00000446617.1 Q5K651 ENST00000379958.3 |